Skip to main content
Equibles
GBCS logo

GBCS · Selectis Health, Inc.

Track GBCS — free

Use GBCS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$5.42 +0.12 (+2.26%) At close · Aug 27
Rebalance outlook locked
Going-concern doubt — cleared Aug 24, 2026

The latest filing states the doubt was alleviated.

“As a result of the Company’s historical losses and projected cash needs, substantial doubt exists about the Company’s ability to continue as a going concern. The focus on opportunities within the Company’s current portfolio and future properties to acquire and operate, the settlement, refinance, and continued service of debt obligations, the potential funds generated from stock sales and other initiatives contributing to additional working capital should alleviate any substantial doubt about the Company’s ability to continue as a going concern.”
View the 10-Q filed Aug 24, 2026
Market Cap
$16.62M
Shares
3.07M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$5.42 Open$5.42 Day$5.42–5.42 52W close$1.50–5.65 Avg vol 30d3K Short int295 · 0.0% float · 1.0d Short vol88% Last earningsMay 26, 2021 DataSep 2021–Aug 2026 Filing10-Q · Aug 24

Raw chart and full-history price indicators begin at the captured split on Sep 22, 2021; bars on opposite sides are not compared.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 24, 2026

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Bearish Fundamentals Excellent Quant / Vol High
Market backdrop VIX 14.4 · calm Equity put/call 0.62
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +78%
above
Price vs 50-day avg +11%
above
RSI (14) 55
neutral
MACD trend Negative
52-week position 94%
near high
Momentum
relative strength
Very Strong
1-month return −1%
trailing
6-month return +158%
trailing
YTD return +143%
this year
Relative strength +143%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $5 › 200d $3 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.01% of float · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Excellent
Revenue growth +16%
Y/Y
EPS growth +58%
Y/Y
Free cash flow $1.4M
Valuation P/E 1.3
below peers
Balance sheet $18.5M
net debt
Quant / Vol
risk profile
High
Volatility 188%
annualized · 1-yr
Max drawdown −74%
past year
ATR 1.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 2 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+78% Bullish
Price vs 50-day avg
+11% Bullish
RSI (14)
55 Neutral
MACD trend
Negative Bearish
52-week position
94% Bullish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $5 › 200d $3 — 50d above 200d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.01% of float · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $2 Now $5 · 94% Range high $6
vs 200-day avg +78% vs 50-day avg +11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
GBCS
Selectis Health, Inc.
this stock
$16.62M +143.0% +15.8% 1.3 0.0%
HCA
HCA Healthcare, Inc.
 $92.69B -10.5% +7.1% 14.4 2.8%
FSNUY
Fresenius SE & Co. KGaA
 $30.05B -6.9% — — 0.0%
THC
Tenet Healthcare Corp
 $21.48B +34.3% +0.9% 10.3 3.1%
FMS
Fresenius Medical Care AG
 $12.29B -3.0% +5.9% — 0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
295
Days to cover
1.0d
Change
+295 sh
View
Short Volume
Short vol %
88%
As of
Aug 27, 2026
Short Total
View
Fails to Deliver
FTD shares
189
Value
$593
As of
May 11, 2026
View
Off-Exchange
Off-exchange %
99.9%
Week of
Jul 20, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$41.4M
Net income (FY)
$-1.0M
EPS diluted
$-0.34
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 24, 2026
This year
11
View
Exempt Offerings
Offering
$750.0K
Filed
Jul 16, 2021
View
Earnings & Events
Earnings Calls
Last call
May 26, 2021
View

Performance

Raw-price comparisons begin at the captured split on Sep 22, 2021; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
GBCS -1.5% -1.5% +158.1% +0.2% +143.1%
SPY +1.1% +4.0% +14.7% +3.2% +13.1%
vs SPY -2.6% -5.4% +143.4% -3.0% +130.0%
Key facts CIK 727346 CUSIP 816291108 Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)